{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:13:51Z","timestamp":1770480831999,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T00:00:00Z","timestamp":1331856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00415-012-6464-z","type":"journal-article","created":{"date-parts":[[2012,3,15]],"date-time":"2012-03-15T14:25:31Z","timestamp":1331821531000},"page":"2105-2110","source":"Crossref","is-referenced-by-count":31,"title":["Elevated plasma homocysteine levels in patients with multiple sclerosis are associated with male gender"],"prefix":"10.1007","volume":"259","author":[{"given":"Stefano","family":"Zoccolella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Iaffaldano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vita","family":"Direnzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"D\u2019Onghia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damiano","family":"Paolicelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Livrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Trojano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,16]]},"reference":[{"key":"6464_CR1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","volume":"343","author":"JH Noseworthy","year":"2000","unstructured":"Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple Sclerosis. N Engl J Med 343:938\u2013952","journal-title":"N Engl J Med"},{"key":"6464_CR2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(03)00438-1","volume":"2","author":"MS Morris","year":"2003","unstructured":"Morris MS (2003) Homocysteine and Alzheimer\u2019s disease. Lancet Neurol 2:425\u2013428","journal-title":"Lancet Neurol"},{"key":"6464_CR3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ajcn\/80.1.114","volume":"80","author":"P Quadri","year":"2004","unstructured":"Quadri P, Fragiacomo C, Pezzati R et al (2004) Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 80:114\u2013122","journal-title":"Am J Clin Nutr"},{"key":"6464_CR4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1212\/01.wnl.0000297193.53986.6f","volume":"70","author":"S Zoccolella","year":"2008","unstructured":"Zoccolella S, Simone IL, Samarelli V et al (2008) Elevated plasma Homocysteine levels in patients with ALS. Neurology 70:222\u2013225","journal-title":"Neurology"},{"key":"6464_CR5","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.WNL.0000137886.74175.5A","volume":"63","author":"RB Postuma","year":"2004","unstructured":"Postuma RB, Lang A (2004) Homocysteine and levodopa. Should Parkinson disease patients receive preventative therapy? Neurology 63:886\u2013891","journal-title":"Neurology"},{"key":"6464_CR6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","volume":"26","author":"MP Mattson","year":"2003","unstructured":"Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26:137\u2013146","journal-title":"Trends Neurosci"},{"key":"6464_CR7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1474-9728.2004.00086.x","volume":"3","author":"L Tjattas","year":"2004","unstructured":"Tjattas L, Ortiz DO, Dhivant S, Mitton K, Rogers E, Shea TB (2004) Folate deficiency and homocysteine induce toxicity in cultured dorsal root ganglion neurons via cytosolic calcium accumulation. Aging Cell 3:71\u201376","journal-title":"Aging Cell"},{"key":"6464_CR8","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.febslet.2006.04.088","volume":"580","author":"R Obeid","year":"2006","unstructured":"Obeid R, Herrmann W (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 580:2994\u20133005","journal-title":"FEBS Lett"},{"issue":"Suppl 2","key":"6464_CR9","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1017\/S0317167100022381","volume":"37","author":"GR Moore","year":"2010","unstructured":"Moore GR (2010) Current concepts in the neuropathology and pathogenesis of multiple sclerosis. Can J Neurol Sci 37(Suppl 2):S5\u2013S15","journal-title":"Can J Neurol Sci"},{"key":"6464_CR10","first-page":"1392","volume":"41","author":"O Stanger","year":"2003","unstructured":"Stanger O, Herrmann W, Pietrzik K et al (2003) DACH-LIGA homocysteine (German, Austrian and Swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 41:1392\u20131403","journal-title":"Clin Chem Lab Med"},{"key":"6464_CR11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1474-4422(11)70105-3","volume":"10","author":"M D\u2019Haeseleer","year":"2011","unstructured":"D\u2019Haeseleer M, Cambron M, Vanopendenbosch L, De Keyser J (2011) Vascular aspects of multiple sclerosis. Lancet Neurol 10:657\u2013666","journal-title":"Lancet Neurol"},{"key":"6464_CR12","first-page":"9","volume":"18","author":"G Salemi","year":"2010","unstructured":"Salemi G, Gueli MC, Vitale F, Battaglieri F et al (2010) Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients. Lipids Health Dis 18:9\u201319","journal-title":"Lipids Health Dis"},{"key":"6464_CR13","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00726-009-0350-8","volume":"38","author":"D Giuseppe Di","year":"2010","unstructured":"Di Giuseppe D, Ulivelli M, Bartalini S et al (2010) Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading test. Amino Acids 38:1461\u20131471","journal-title":"Amino Acids"},{"key":"6464_CR14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jocn.2008.05.015","volume":"16","author":"B Kocer","year":"2009","unstructured":"Kocer B, Engur S, Ak F, Yilmaz M (2009) Serum vitamin B12, folate, and homocysteine levels and their association with clinical and electrophysiological parameters in multiple sclerosis. J Clin Neurosci 16:399\u2013403","journal-title":"J Clin Neurosci"},{"key":"6464_CR15","first-page":"7","volume":"9","author":"N Triantafyllou","year":"2008","unstructured":"Triantafyllou N, Evangelopoulos ME, Kimiskidis VK et al (2008) Increased plasma homocysteine levels in patients with multiple sclerosis and depression. Ann Gen Psychiatry 9:7\u201317","journal-title":"Ann Gen Psychiatry"},{"key":"6464_CR16","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/jnnp.2008.151555","volume":"79","author":"CE Teunissen","year":"2008","unstructured":"Teunissen CE, Killestein J, Kragt JJ, Polman CH, Dijkstra CD, Blom HJ (2008) Serum homocysteine levels in relation to clinical progression in multiple sclerosis. J Neurol Neurosurg Psychiatry 79:1349\u20131353","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6464_CR17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00415-007-0668-7","volume":"255","author":"C Russo","year":"2008","unstructured":"Russo C, Morabito F, Luise F et al (2008) Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis. J Neurol 255:64\u201369","journal-title":"J Neurol"},{"key":"6464_CR18","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1177\/1352458506075503","volume":"13","author":"S Sahin","year":"2007","unstructured":"Sahin S, Aksungar FB, Topkaya AE et al (2007) Increased plasma homocysteine levels in multiple sclerosis. Mult Scler 13:945\u2013946","journal-title":"Mult Scler"},{"key":"6464_CR19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.2005.072199","volume":"77","author":"GS Ramsaransing","year":"2006","unstructured":"Ramsaransing GS, Fokkema MR, Teelken A, Arutjunyan AV, Koch M, De Keyser J (2006) Plasma homocysteine levels in multiple sclerosis. J Neurol Neurosurg Psychiatry 77:189\u2013192","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6464_CR20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1515\/CCLM.2005.190","volume":"43","author":"CE Teunissen","year":"2005","unstructured":"Teunissen CE, van Boxtel MP, Jolles J et al (2005) Homocysteine in relation to cognitive performance in pathological and non-pathological conditions. Clin Chem Lab Med 43:1089\u20131095","journal-title":"Clin Chem Lab Med"},{"key":"6464_CR21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1191\/1352458503ms918oa","volume":"9","author":"M Vrethem","year":"2003","unstructured":"Vrethem M, Mattsson E, Hebelka H et al (2003) Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid. Mult Scler 9:239\u2013245","journal-title":"Mult Scler"},{"key":"6464_CR22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/1028415031000115945","volume":"6","author":"HT Besler","year":"2003","unstructured":"Besler HT, Como\u011flu S (2003) Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutr Neurosci 6:189\u2013196","journal-title":"Nutr Neurosci"},{"key":"6464_CR23","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archneur.1994.00540230048011","volume":"51","author":"DE Goodkin","year":"1994","unstructured":"Goodkin DE, Jacobsen DW, Galvez N, Daughtry M, Secic M, Green R (1994) Serum cobalamin deficiency is uncommon in multiple sclerosis. Arch Neurol 51:1110\u20131114","journal-title":"Arch Neurol"},{"key":"6464_CR24","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archneur.1994.00540240025007","volume":"51","author":"J Rio","year":"1994","unstructured":"Rio J, Montalban J, Tintore M, Codina A, Malinow MR (1994) Serum homocysteine levels in multiple sclerosis. Arch Neurol 51:1181","journal-title":"Arch Neurol"},{"key":"6464_CR25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d. Ann Neurol 58:840\u2013846","journal-title":"Ann Neurol"},{"key":"6464_CR26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292\u2013302","journal-title":"Ann Neurol"},{"key":"6464_CR27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0378-4347(91)80407-4","volume":"565","author":"JB Ubbink","year":"1991","unstructured":"Ubbink JB, Hayward Vermaak WJ, Bissbort S (1991) Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565:441\u2013446","journal-title":"J Chromatogr"},{"key":"6464_CR28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/brain\/122.5.871","volume":"122","author":"GR Cutter","year":"1999","unstructured":"Cutter GR, Baier ML, Rudick RA et al (1999) Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 122:871\u2013882","journal-title":"Brain"},{"key":"6464_CR29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jocn.2010.12.022","volume":"18","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, He ZY, Liu HN (2011) Meta-analysis of the relationship between homocysteine, vitamin B12, folate and multiple sclerosis. J Clin Neurosci 18:933\u2013938","journal-title":"J Clin Neurosci"},{"key":"6464_CR30","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1124\/jpet.106.107185","volume":"319","author":"YF Fu","year":"2006","unstructured":"Fu YF, Zhu YN, Ni J, Zhong XG et al (2006) A reversible S-adenosyl-l-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation. J Pharmacol Exp Ther 319:799\u2013808","journal-title":"J Pharmacol Exp Ther"},{"key":"6464_CR31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0021-9150(01)00670-0","volume":"161","author":"T Koga","year":"2002","unstructured":"Koga T, Claycombe K, Meydani M (2002) Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis 161:365\u2013374","journal-title":"Atherosclerosis"},{"key":"6464_CR32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1357-2725(97)00009-5","volume":"29","author":"S Kim","year":"1997","unstructured":"Kim S, Lim IK, Park GH, Paik WK (1997) Biological methylation of myelin basic protein: enzymology and biological significance. Int J Biochem Cell Biol 29:743\u2013751","journal-title":"Int J Biochem Cell Biol"},{"key":"6464_CR33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2011.03.003","volume":"234","author":"JM Greer","year":"2011","unstructured":"Greer JM, McCombe PA (2011) Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J Neuroimmunol 234:7\u201318","journal-title":"J Neuroimmunol"},{"key":"6464_CR34","first-page":"1438","volume":"41","author":"K Schoecksnadel","year":"2003","unstructured":"Schoecksnadel K, Frick B, Wincler C, Leblhuber F, Wirleitner B, Fuchs D (2003) Hyperhomocysteinemia and immune activation. Clin Chem Lab Med 41:1438\u20131443","journal-title":"Clin Chem Lab Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-012-6464-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6464-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T07:01:42Z","timestamp":1742713302000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-012-6464-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,16]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["6464"],"URL":"https:\/\/doi.org\/10.1007\/s00415-012-6464-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,16]]}}}